全球医学量子计算市场:按组件、按部署(本地、基于云)、按技术(超导量子位、离子阱)、按应用(药物发现、基因组学)、按最终用户、按地区 - 预测2028年
市场调查报告书
商品编码
1277590

全球医学量子计算市场:按组件、按部署(本地、基于云)、按技术(超导量子位、离子阱)、按应用(药物发现、基因组学)、按最终用户、按地区 - 预测2028年

Quantum Computing in Healthcare Market by Component (Hardware, Software), Deployment (0n-premises, Cloud-based), Technology (Superconducting qubits, Trapped ions), Application (Drug discovery, Genomics), End User, and Region - Global Forecast to 2028

出版日期: | 出版商: MarketsandMarkets | 英文 210 Pages | 订单完成后即时交付

价格
简介目录

到 2028 年,全球医学量子计算市场规模将从 2023 年的 8500 万美元增长到 5.03 亿美元,复合年增长率高达 42.5% 预计在预测期内实现增长。

支持各种医疗应用的量子计算技术进步将在预测期内为市场提供有利可图的机会。

“根据医疗量子计算市场部署,基于云的细分市场在预测期内的复合年增长率最高”

到 2022 年,基于云的部分将占据医学量子计算市场的很大份额。 基于云的部分的增长是由快速发展的量子计算系统的有限寿命、轻鬆的可扩展性和灵活性以及最终在利用量子云服务时改进决策过程所推动的。这可能是由于

“超导量子比特在医学量子计算市场中所占技术份额最大”

到 2022 年,超导量子位部分在医疗量子计算市场中占据最大份额。 这么大的份额是由于使用超导量子位的量子计算系统的快速门速度和这种类型的量子位可能的高度控制,这导致了药物发现、诊断成像和个性化医疗等各种应用。这是可能是因为它可以灵活地用于

“到 2022 年,製药和生物製药公司细分市场将成为医疗量子计算市场中终端用户最大的细分市场”

到 2022 年,製药和生物製药公司将占据医疗量子计算市场的很大份额。 製药和生物製药领域的增长受到量子计算的推动,它通过减少对目标识别、药物设计和毒性测试的反复试验的依赖,大大加快了研发的速度和更有针对性。因为它可以准确地进行,它被认为领先加快复杂的药物发现和开发程序并提高准确性。 从长远来看,好处包括更好地利用资源和资本、提高投资回报率以及显着增加慢性病新药的供应。

“亚太地区将在预测期内表现出最高的增长率”

在预测期内,亚太市场预计将以最高复合年增长率增长。 因素包括对用于研究和基因组学目的的量子计算等先进技术的需求不断增加,新兴地区对量子计算的认识和采用不断增加,以及改善医疗保健基础设施。

内容

第一章介绍

第二章研究方法论

第 3 章执行摘要

第 4 章重要注意事项

第 5 章市场概述

  • 简介
  • 市场动态
    • 市场驱动因素
    • 约束因素
    • 机会
    • 任务

第 6 章行业注意事项

  • 行业趋势
  • 技术分析
  • 波特的五力分析
  • 监管分析
  • 价值链分析
  • 生态系统分析
  • 专利分析
  • 案例研究分析
  • 主要利益相关者和采购标准
  • 主要会议和活动 (2023-2024)
  • 影响客户业务的趋势/颠覆

第 7 章医学量子计算市场:按组件分类

  • 简介
  • 软件
  • 硬件
  • 服务

第 8 章医学量子计算市场:按部署

  • 简介
  • 本地
  • 基于云

第 9 章医学量子计算市场:按技术分类

  • 简介
  • 超导量子比特
  • 离子阱类型
  • 量子退火
  • 其他

第 10 章医学量子计算市场:按应用

  • 简介
  • 药物发现和开发
  • 医学诊断
  • 基因组学和精准医学
  • 放射治疗
  • 风险分析
  • 其他(PHM、医疗保障)

第 11 章医学量子计算市场:按最终用户分类

  • 简介
  • 製药和生物製药公司
  • 研究所和研究所
  • 医疗保健提供者
  • 医疗保险公司

第 12 章医疗量子计算市场:按地区

  • 简介
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 亚太其他地区
  • 其他地区

第13章竞争格局

  • 概览
  • 市场排名分析
  • 顶级市场公司的收入份额分析
  • 医学量子计算市场:研发支出
  • 主要公司按地区划分的收入评估
  • 竞争基准
  • 企业评估象限
  • 初创公司/中小企业的企业评估象限
  • 竞争场景

第14章公司简介

  • 主要公司
    • RIGETTI & CO, LLC.
    • IBM
    • D-WAVE QUANTUM INC.
    • QUANDELA
    • IONQ
    • QUANTINUUM LTD.
    • GOOGLE LLC
    • ID QUANTIQUE
    • ZAPATA COMPUTING
    • ATOS SE
    • QC WARE
    • CLASSIQ TECHNOLOGIES LTD.
    • XANADU QUANTUM TECHNOLOGIES INC.
    • HEFEI ORIGIN QUANTUM COMPUTING TECHNOLOGY CO., LTD.
    • PROTIVITI INC.
    • PWC
    • DELOITTE
    • ACCENTURE
  • 其他企业
    • AMAZON WEB SERVICES(AWS)
    • PASQAL
    • FUJITSU
    • SANDBOX AQ
    • SEEQC
    • QUINTESSENCELABS
    • QNAMI

第15章 附录

简介目录
Product Code: HIT 8637

The global quantum computing in healthcare market is projected to reach USD 503 million by 2028 from USD 85 million in 2023, at a high CAGR of 42.5% during the forecast period. The technological advancements in quantum computing supporting various healthcare applications will provide lucrative opportunities to the market during the forecast period.

"The cloud based segment registered the highest CAGR during the forecast period in healthcare market, by deployment "

In 2022, the cloud-based segment accounted for a significant share of the quantum computing in healthcare market. The growth of the cloud-based segment can be attributed to the limited lifespan of rapidly advancing quantum computing systems, hassle-free scalability and flexibility, which in turn improves the ultimate decision-making process while using the quantum cloud services.

"Superconducting Qubits segment accounted for the largest share of the quantum computing in healthcare market, By Technology"

In 2022, the superconducting qubits segment accounted for the largest share of the quantum computing in healthcare market. The large share can be attributed to the fast gate speed of quantum computing systems based on superconducting qubits and the high degree of control possible with this type of qubit, making them flexible to be used for various applications such as drug discovery, imaging diagnostics, personalized medicine, etc.

"Pharmaceutical and Biopharmaceutical companies was the largest segment by end user of quantum computing in healthcare market in 2022"

In 2022, the pharmaceutical & biopharmaceutical companies segment accounted for a significant share of the quantum computing in healthcare market. The growth of the pharmaceutical & biopharmaceutical companies segment can be attributed to the ability of quantum computing to make R&D dramatically faster and more targeted and precise by making target identification, drug design, and toxicity testing less dependent on trial and error and therefore expedite complex drug discovery & development procedures, and enhanced accuracy. Its long-term benefits include the better utilization of resources and capital, better return on investment, and a substantial increase in the delivery of new medicines for chronic diseases.

"APAC to witness the highest growth rate during the forecast period."

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Factors such as growing demand for advanced technologies such as quantum computing for research & genomics purposes, growing awareness and adoption of quantum computing in emerging regions, and improving healthcare infrastructure.

The break-down of primary participants is as mentioned below:

  • By Company Type - Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
  • By Designation - C-level: 42%, Director-level: 31%, and Others: 27%
  • By Region - North America: 32%, Europe: 32%, Asia Pacific: 26%, Middle East & Africa: 5%, Latin America: 5%

Key Players in the Quantum Computing In Healthcare Market

The key players operating in the Quantum Computing in Healthcare Market include IBM (US), Google, Inc. (US), Rigetti & Co, LLC. (US), Quandela (France), D-Wave Quantum Inc. (Canada), Quantinuum, Ltd. (US & UK), ID Quantique (Switzerland), Zapata Computing (US), Atos SE (France), IonQ (US), Classiq Technologies, Inc. (US), Xanadu Quantum Technologies Inc. (Canada), QC Ware (California), Protiviti, Inc. (US), Hefei Origin Quantum Computing Technology Co., Ltd. (China), PwC (UK), Deloitte (UK), Accenture (Ireland), Amazon Web Services (US), Pasqal (France), Fujitsu (Japan), Sandbox AQ (US), SEEQC (US), Quintessence Labs (Australia), and Qnami (Switzerland).

Research Coverage:

The report analyzes the Quantum Computing in Healthcare Market and aims to estimate the market size and future growth potential of various market segments, based on components, deployment mode, application, technology, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

  • Analysis of key drivers (increasing Investments in quantum computing in developed as well as emerging economies, growing inclination of payers toward quantum computing, rising demand for personalized medicine, increasing funding and investments in quantum computing startups), restraints (accuracy issues with quantum computing systems and high implementation costs), opportunities (technological advancements in quantum computing supporting various healthcare applications, potential applications in medical image analysis and oncology),and challenges (lack of technical expertise & data management issues) influencing the growth of the healthcare interoperability solutions market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the quantum computing in healthcare market.
  • Market Development: Comprehensive information on the lucrative emerging markets, component, deployment mode, technology, application, end user, and region.
  • Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the quantum computing in healthcare market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the quantum computing in healthcare market like IBM (US), Google, Inc. (US), Rigetti & Co, LLC. (US), Quandela (France), D-Wave Quantum Inc. (Canada), Quantinuum, Ltd. (US & UK).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • TABLE 1 INCLUSIONS & EXCLUSIONS
  • 1.3 STUDY SCOPE
    • 1.3.1 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY REGION
    • 1.3.2 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
    • TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
  • 1.5 STAKEHOLDERS
  • 1.6 LIMITATIONS
  • 1.7 IMPACT OF RECESSION

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY RESEARCH
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY RESEARCH
      • 2.1.2.1 Primary sources
      • 2.1.2.2 Key data from primary sources
      • 2.1.2.3 Breakdown of primaries
    • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
      • 2.1.2.4 Insights from primary experts
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 3 BOTTOM-UP APPROACH
    • FIGURE 4 TOP-DOWN APPROACH
    • FIGURE 5 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF QUANTUM COMPUTING IN HEALTHCARE INDUSTRY
    • FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • 2.3 MARKET BREAKDOWN DATA TRIANGULATION
    • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
    • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.7 RISK ASSESSMENT
    • TABLE 3 RISK ASSESSMENT: QUANTUM COMPUTING IN HEALTHCARE MARKET
  • 2.8 IMPACT OF RECESSION ON QUANTUM COMPUTING IN HEALTHCARE MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 8 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023 VS. 2028 (USD MILLION)
    • FIGURE 9 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023 VS. 2028 (USD MILLION)
    • FIGURE 10 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
    • FIGURE 11 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 QUANTUM COMPUTING IN HEALTHCARE MARKET: REGIONAL SNAPSHOT

4 PREMIUM INSIGHTS

  • 4.1 OVERVIEW OF QUANTUM COMPUTING IN HEALTHCARE MARKET
    • FIGURE 14 GOVERNMENT SUPPORT FOR ADOPTION OF QUANTUM COMPUTING TO DRIVE MARKET GROWTH
  • 4.2 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT
    • FIGURE 15 HARDWARE SEGMENT AND JAPAN TO COMMAND LARGEST SHARES OF ASIA PACIFIC MARKET IN 2022
  • 4.3 GEOGRAPHIC SNAPSHOT OF QUANTUM COMPUTING IN HEALTHCARE MARKET
    • FIGURE 16 MARKET IN CHINA TO GROW AT HIGHEST CAGR
  • 4.4 REGIONAL MIX: QUANTUM COMPUTING IN HEALTHCARE MARKET
    • FIGURE 17 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 18 QUANTUM COMPUTING IN HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • TABLE 4 MARKET DYNAMICS: QUANTUM COMPUTING IN HEALTHCARE MARKET
    • 5.2.1 MARKET DRIVERS
      • 5.2.1.1 Increasing investments in quantum computing in developed as well as emerging economies
      • 5.2.1.2 Growing inclination of payers toward quantum computing
      • 5.2.1.3 Rising demand for personalized medicine
      • 5.2.1.4 Increasing funding and investments in quantum computing startups
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Accuracy issues with quantum computing systems and high implementation costs
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Technological advancements in quantum computing supporting various healthcare applications
      • 5.2.3.2 Potential applications in medical image analysis and oncology
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Lack of technical expertise and data management issues

6 INDUSTRY INSIGHTS

  • 6.1 INDUSTRY TRENDS
    • 6.1.1 HYBRID QUANTUM-CLASSICAL COMPUTING
    • 6.1.2 QUANTUM MACHINE LEARNING
    • 6.1.3 GROWING NUMBER OF APPLICATIONS IN HEALTHCARE INDUSTRY
  • 6.2 TECHNOLOGY ANALYSIS
    • 6.2.1 QUANTUM ARTIFICIAL INTELLIGENCE
    • 6.2.2 QUANTUM COMMUNICATION TECHNOLOGY
    • 6.2.3 QUANTUM COMPUTING ACADEMIA
    • 6.2.4 CYBERSECURITY TRANSFORMATION
    • 6.2.5 QUANTUM SENSING
  • 6.3 PORTER'S FIVE FORCES ANALYSIS
    • FIGURE 19 QUANTUM COMPUTING MARKET: PORTER'S FIVE FORCES ANALYSIS
  • 6.4 REGULATORY ANALYSIS
    • 6.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 8 ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 6.4.2 REGULATORY STANDARDS
      • 6.4.2.1 P1913 - Software-defined quantum communication
      • 6.4.2.2 P7130 - Standard for quantum technologies definitions
      • 6.4.2.3 P7131 - Standard for quantum computing performance metrics and benchmarking
  • 6.5 VALUE CHAIN ANALYSIS
    • FIGURE 20 QUANTUM COMPUTING IN HEALTHCARE MARKET: VALUE CHAIN ANALYSIS
    • 6.5.1 RESEARCH, DESIGN, AND DEVELOPMENT
    • 6.5.2 MANUFACTURERS & SERVICE PROVIDERS
    • 6.5.3 MARKETING & SALES EXECUTIVES
    • 6.5.4 END USERS
  • 6.6 ECOSYSTEM ANALYSIS
    • FIGURE 21 QUANTUM COMPUTING IN HEALTHCARE MARKET: ECOSYSTEM ANALYSIS
  • 6.7 PATENT ANALYSIS
    • FIGURE 22 TOP PATENT OWNERS AND APPLICANTS FOR HEALTHCARE IT SOLUTIONS (JANUARY 2011-APRIL 2023)
    • FIGURE 23 PATENT ANALYSIS: QUANTUM COMPUTING IN HEALTHCARE MARKET (JANUARY 2015-APRIL 2023)
  • 6.8 CASE STUDY ANALYSIS
    • TABLE 9 MENTEN AI LEVERAGED D-WAVE QUANTUM COMPUTING PRODUCTS TO BATTLE COVID-19 WITH QUANTUM PEPTIDE THERAPEUTICS
  • 6.9 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 6.9.1 KEY STAKEHOLDERS ON BUYING PROCESS
    • FIGURE 24 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS
    • TABLE 10 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%)
    • 6.9.2 BUYING CRITERIA
    • FIGURE 25 KEY BUYING CRITERIA FOR QUANTUM COMPUTING BY COMPONENTS
    • TABLE 11 KEY BUYING CRITERIA FOR QUANTUM COMPUTING BY COMPONENT
  • 6.10 KEY CONFERENCES AND EVENTS (2023-2024)
  • 6.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 26 REVENUE SHIFT IN QUANTUM COMPUTING IN HEALTHCARE MARKET

7 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT

  • 7.1 INTRODUCTION
    • TABLE 12 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
  • 7.2 SOFTWARE
    • 7.2.1 SHIFT TO WEB/CLOUD-BASED MODELS TO SUPPORT GROWTH
    • TABLE 13 QUANTUM COMPUTING IN HEALTHCARE SOFTWARE OFFERED BY KEY MARKET PLAYERS
    • TABLE 14 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR SOFTWARE, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.3 HARDWARE
    • 7.3.1 NEED FOR FREQUENT HARDWARE UPGRADES TO DRIVE MARKET GROWTH
    • TABLE 15 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR HARDWARE, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.4 SERVICES
    • 7.4.1 INTRODUCTION OF COMPLEX SOFTWARE TO DRIVE DEMAND FOR SERVICES
    • TABLE 16 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)

8 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT

  • 8.1 INTRODUCTION
    • TABLE 17 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021-2028 (USD MILLION)
  • 8.2 ON-PREMISES
    • 8.2.1 RISING DEPLOYMENT OF ON-PREMISES QUANTUM COMPUTERS BY ORGANIZATIONS TO ENSURE DATA SECURITY
    • TABLE 18 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR ON-PREMISES SOLUTIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.3 CLOUD-BASED
    • 8.3.1 INCREASING PREFERENCE FOR CLOUD-BASED QUANTUM COMPUTING FOR RESEARCH & DEVELOPMENT USING DIFFERENT APPROACHES
    • TABLE 19 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR CLOUD-BASED SOLUTIONS, BY COUNTRY, 2021-2028 (USD MILLION)

9 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY

  • 9.1 INTRODUCTION
    • TABLE 20 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • 9.2 SUPERCONDUCTING QUBITS
    • 9.2.1 LOW POWER CONSUMPTION, HIGH SPEED, AND ABILITY TO OPERATE AT LOW TEMPERATURES TO DRIVE MARKET
    • TABLE 21 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR SUPERCONDUCTING QUBITS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.3 TRAPPED IONS
    • 9.3.1 SUPERIOR CONNECTIVITY AND HIGHER GATE FIDELITY TO DRIVE MARKET
    • TABLE 22 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR TRAPPED IONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.4 QUANTUM ANNEALING
    • 9.4.1 QUICK DISCOVERY OF MOST EFFICIENT CONFIGURATIONS AMONG POSSIBLE COMBINATIONS OF VARIABLES TO DRIVE MARKET
    • TABLE 23 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR QUANTUM ANNEALING, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.5 OTHERS
    • TABLE 24 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021-2028 (USD MILLION)

10 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION

  • 10.1 INTRODUCTION
    • TABLE 25 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 10.2 DRUG DISCOVERY & DEVELOPMENT
    • 10.2.1 ENABLING ACCURATE DATA PROJECTIONS AND SOLUTIONS FOR DRUG DISCOVERY AND DEVELOPMENT TO BOOST MARKET GROWTH
    • TABLE 26 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021-2028 (USD MILLION)
  • 10.3 MEDICAL DIAGNOSTICS
    • 10.3.1 PRECISE AND SENSITIVE MEDICAL DIAGNOSTICS PROCEDURES TO DRIVE MARKET
    • TABLE 27 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR MEDICAL DIAGNOSTICS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 10.4 GENOMICS & PRECISION MEDICINE
    • 10.4.1 UNLOCKING POWER OF GENOMICS & PRECISION MEDICINE WITH QUANTUM COMPUTING TECHNOLOGY
    • TABLE 28 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR GENOMICS & PRECISION MEDICINE, BY COUNTRY, 2021-2028 (USD MILLION)
  • 10.5 RADIOTHERAPY
    • 10.5.1 QUANTUM RADIOTHERAPY: ENABLING MORE PERSONALIZED AND PRECISE TREATMENT IN FIGHT AGAINST CANCER
    • TABLE 29 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR RADIOTHERAPY, BY COUNTRY, 2021-2028 (USD MILLION)
  • 10.6 RISK ANALYSIS
    • 10.6.1 ENHANCES PRICING MODEL MANAGEMENT AND DECREASE IN COSTS ASSOCIATED WITH FRAUD
    • TABLE 30 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR RISK ANALYSIS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 10.7 OTHERS (POPULATION HEALTH MANAGEMENT, SECURITY IN HEALTHCARE)
    • 10.7.1 SECURELY TRANSFORMING POPULATION HEALTH WITH QUANTUM COMPUTING
    • TABLE 31 QUANTUM COMPUTING IN HEALTHCARE MARKET OTHER APPLICATIONS (POPULATION HEALTH MANAGEMENT, SECURITY IN HEALTHCARE), BY COUNTRY, 2021-2028 (USD MILLION)

11 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY END USER

  • 11.1 INTRODUCTION
    • TABLE 32 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.2 PHARMA & BIOPHARMA COMPANIES
    • 11.2.1 RISING DEMAND FOR SOLUTIONS TO REDUCE TIME AND COSTS OF DRUG DEVELOPMENT
    • TABLE 33 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR PHARMA & BIOPHARMA COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 11.3 LABS & RESEARCH INSTITUTES
    • 11.3.1 INCREASED RESEARCH ACTIVITIES TO ENCOURAGE USE OF AI IN GENOMICS IN ACADEMIC AND GOVERNMENT INSTITUTES
    • TABLE 34 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR LABS & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 11.4 HEALTHCARE PROVIDERS
    • 11.4.1 HIGH NUMBER OF BENEFITS TO IMPROVE PATIENT MANAGEMENT, LOWER COSTS, AND DELIVER BETTER PATIENT TREATMENT
    • TABLE 35 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 11.5 HEALTHCARE PAYERS
    • 11.5.1 POTENTIAL TO REDUCE READMISSIONS AND OVERHEAD COSTS TO DRIVE ADOPTION
    • TABLE 36 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2021-2028 (USD MILLION)

12 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY REGION

  • 12.1 INTRODUCTION
    • TABLE 37 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 12.2 NORTH AMERICA
    • FIGURE 27 NORTH AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET SNAPSHOT, 2022
    • TABLE 38 NORTH AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 39 NORTH AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 40 NORTH AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021-2028 (USD MILLION)
    • TABLE 41 NORTH AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 42 NORTH AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 43 NORTH AMERICA: QUANTUM COMPUTING IN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.2.1 US
      • 12.2.1.1 Expanding applications of quantum computing in healthcare to bolster market growth
    • TABLE 44 US: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 45 US: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021-2028 (USD MILLION)
    • TABLE 46 US: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 47 US: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 48 US: QUANTUM COMPUTING IN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.2.2 CANADA
      • 12.2.2.1 Investments and developments in quantum computing industry to drive market
    • TABLE 49 CANADA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 50 CANADA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021-2028 (USD MILLION)
    • TABLE 51 CANADA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 52 CANADA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 53 CANADA: QUANTUM COMPUTING IN MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 12.3 EUROPE
    • TABLE 54 EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 55 EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 56 EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021-2028 (USD MILLION)
    • TABLE 57 EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 58 EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 59 EUROPE: QUANTUM COMPUTING IN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.3.1 GERMANY
      • 12.3.1.1 Collaborations & partnerships to drive adoption of quantum computing solutions
    • TABLE 60 GERMANY: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 61 GERMANY: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021-2028 (USD MILLION)
    • TABLE 62 GERMANY: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 63 GERMANY: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 64 GERMANY: QUANTUM COMPUTING IN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.3.2 UK
      • 12.3.2.1 Increased focus on quantum computing applications to support growth
    • TABLE 65 UK: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 66 UK: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021-2028 (USD MILLION)
    • TABLE 67 UK: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 68 UK: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 69 UK: QUANTUM COMPUTING IN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.3.3 FRANCE
      • 12.3.3.1 Government funding for quantum computing to bolster growth
    • TABLE 70 FRANCE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 71 FRANCE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021-2028 (USD MILLION)
    • TABLE 72 FRANCE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 73 FRANCE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 74 FRANCE: QUANTUM COMPUTING IN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.3.4 REST OF EUROPE
    • TABLE 75 REST OF EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 76 REST OF EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021-2028 (USD MILLION)
    • TABLE 77 REST OF EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 78 REST OF EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 79 REST OF EUROPE: QUANTUM COMPUTING IN MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 12.4 ASIA PACIFIC
    • FIGURE 28 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE SNAPSHOT
    • TABLE 80 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 81 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 82 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021-2028 (USD MILLION)
    • TABLE 83 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 84 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 85 ASIA PACIFIC: QUANTUM COMPUTING IN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.4.1 JAPAN
      • 12.4.1.1 Rising penetration of technologies to support market growth
    • TABLE 86 JAPAN: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 87 JAPAN: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021-2028 (USD MILLION)
    • TABLE 88 JAPAN: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 89 JAPAN: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 90 JAPAN: QUANTUM COMPUTING IN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.4.2 CHINA
      • 12.4.2.1 Dominating healthcare market in Asia Pacific
    • TABLE 91 CHINA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 92 CHINA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021-2028 (USD MILLION)
    • TABLE 93 CHINA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 94 CHINA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 95 CHINA: QUANTUM COMPUTING IN MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.4.3 REST OF ASIA PACIFIC
    • TABLE 96 REST OF ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 97 REST OF ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021-2028 (USD MILLION)
    • TABLE 98 REST OF ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 99 REST OF ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 100 REST OF ASIA PACIFIC: QUANTUM COMPUTING IN MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 12.5 REST OF THE WORLD
    • TABLE 101 REST OF THE WORLD: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
    • TABLE 102 REST OF THE WORLD: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2021-2028 (USD MILLION)
    • TABLE 103 REST OF THE WORLD: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 104 REST OF THE WORLD: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 105 REST OF THE WORLD: QUANTUM COMPUTING IN MARKET, BY END USER, 2021-2028 (USD MILLION)

13 COMPETITIVE LANDSCAPE

  • 13.1 OVERVIEW
    • FIGURE 29 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN JANUARY 2020 AND APRIL 2023
  • 13.2 MARKET RANKING ANALYSIS
    • FIGURE 30 QUANTUM COMPUTING IN HEALTHCARE MARKET RANKING ANALYSIS, BY PLAYER, 2022
  • 13.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
    • FIGURE 31 QUANTUM COMPUTING IN HEALTHCARE MARKET: REVENUE ANALYSIS OF KEY PLAYERS
  • 13.4 QUANTUM COMPUTING IN HEALTHCARE MARKET: R&D EXPENDITURE
    • FIGURE 32 R&D EXPENDITURE OF KEY PLAYERS (2021 VS. 2022)
  • 13.5 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS
    • FIGURE 33 QUANTUM COMPUTING IN HEALTHCARE MARKET: GEOGRAPHIC REVENUE MIX
  • 13.6 COMPETITIVE BENCHMARKING
    • TABLE 106 FOOTPRINTS OF COMPANIES IN QUANTUM COMPUTING IN HEALTHCARE MARKET
    • TABLE 107 COMPANY PRODUCT FOOTPRINT (26 COMPANIES)
    • TABLE 108 COMPANY APPLICATION FOOTPRINT (16 COMPANIES)
    • TABLE 109 COMPANY REGION FOOTPRINT (25 COMPANIES)
  • 13.7 COMPANY EVALUATION QUADRANT
    • 13.7.1 STARS
    • 13.7.2 EMERGING LEADERS
    • 13.7.3 PERVASIVE PLAYERS
    • 13.7.4 PARTICIPANTS
    • FIGURE 34 QUANTUM COMPUTING IN HEALTHCARE MARKET: COMPANY EVALUATION QUADRANT (2022)
  • 13.8 COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES
    • 13.8.1 PROGRESSIVE COMPANIES
    • 13.8.2 DYNAMIC COMPANIES
    • 13.8.3 RESPONSIVE COMPANIES
    • 13.8.4 STARTING BLOCKS
    • FIGURE 35 QUANTUM COMPUTING IN HEALTHCARE MARKET: COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES (2022)
  • 13.9 COMPETITIVE SCENARIO
    • 13.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS
    • TABLE 110 PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2020- APRIL 2023
    • 13.9.2 DEALS
    • TABLE 111 DEALS, JANUARY 2020- APRIL 2023

14 COMPANY PROFILES

  • (Business overview, Products/Solutions/Services offered, Recent Developments, MNM view)**
  • 14.1 KEY PLAYERS
    • 14.1.1 RIGETTI & CO, LLC.
    • TABLE 112 RIGETTI & CO, LLC.: COMPANY OVERVIEW
    • FIGURE 36 RIGETTI & CO, LLC.: COMPANY SNAPSHOT (2022)
    • 14.1.2 IBM
    • TABLE 113 IBM: COMPANY OVERVIEW
    • FIGURE 37 IBM: COMPANY SNAPSHOT (2022)
    • 14.1.3 D-WAVE QUANTUM INC.
    • TABLE 114 D-WAVE QUANTUM INC.: COMPANY OVERVIEW
    • FIGURE 38 D-WAVE QUANTUM INC.: COMPANY SNAPSHOT (2022)
    • 14.1.4 QUANDELA
    • TABLE 115 QUANDELA: COMPANY OVERVIEW
    • 14.1.5 IONQ
    • TABLE 116 IONQ: COMPANY OVERVIEW
    • FIGURE 39 IONQ: COMPANY SNAPSHOT (2022)
    • 14.1.6 QUANTINUUM LTD.
    • TABLE 117 QUANTINUUM LTD.: COMPANY OVERVIEW
    • 14.1.7 GOOGLE LLC
    • TABLE 118 GOOGLE LLC: COMPANY OVERVIEW
    • FIGURE 40 GOOGLE LLC: COMPANY SNAPSHOT (2022)
    • 14.1.8 ID QUANTIQUE
    • TABLE 119 ID QUANTIQUE: COMPANY OVERVIEW
    • 14.1.9 ZAPATA COMPUTING
    • TABLE 120 ZAPATA COMPUTING: COMPANY OVERVIEW
    • 14.1.10 ATOS SE
    • TABLE 121 ATOS SE: COMPANY OVERVIEW
    • FIGURE 41 ATOS SE: COMPANY SNAPSHOT (2022)
    • 14.1.11 QC WARE
    • TABLE 122 QC WARE: COMPANY OVERVIEW
    • 14.1.12 CLASSIQ TECHNOLOGIES LTD.
    • TABLE 123 CLASSIQ TECHNOLOGIES LTD.: COMPANY OVERVIEW
    • 14.1.13 XANADU QUANTUM TECHNOLOGIES INC.
    • TABLE 124 XANADU QUANTUM TECHNOLOGIES INC.: COMPANY OVERVIEW
    • 14.1.14 HEFEI ORIGIN QUANTUM COMPUTING TECHNOLOGY CO., LTD.
    • TABLE 125 HEFEI ORIGIN QUANTUM COMPUTING TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
    • 14.1.15 PROTIVITI INC.
    • TABLE 126 PROTIVITI INC.: COMPANY OVERVIEW
    • 14.1.16 PWC
    • TABLE 127 PWC: COMPANY OVERVIEW
    • 14.1.17 DELOITTE
    • TABLE 128 DELOITTE: COMPANY OVERVIEW
    • 14.1.18 ACCENTURE
    • TABLE 129 ACCENTURE: COMPANY OVERVIEW
    • FIGURE 42 ACCENTURE: COMPANY SNAPSHOT (2022)
  • 14.2 OTHER PLAYERS
    • 14.2.1 AMAZON WEB SERVICES (AWS)
    • 14.2.2 PASQAL
    • 14.2.3 FUJITSU
    • 14.2.4 SANDBOX AQ
    • 14.2.5 SEEQC
    • 14.2.6 QUINTESSENCELABS
    • 14.2.7 QNAMI
  • *Details on Business overview, Products/Solutions/Services offered, Recent Developments, MNM view might not be captured in case of unlisted companies.

15 APPENDIX

  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS